🕵️ AN2 Therapeutics, Inc. ($ANTX)
SEC insider & ownership activity, last 12 months · CIK 1880438 · every row links its SEC filing
Over the last 12 months insiders sold $80K with no open-market buying against it. Joshua M. Eizen sold $53K (Nov–Jul). Eric Easom added 6.2% → 7.9%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $80K (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Joshua M. Eizen | 0 | – | 4 | $53K | Jul 8, 2026 |
| Chanda Sanjay | 0 | – | 2 | $9K | Jan 6, 2026 |
| Day Lucy | 0 | – | 2 | $9K | Jan 6, 2026 |
| Prior Stephen David | 0 | – | 3 | $7K | Jan 6, 2026 |
| Williams Sarah Joanne | 0 | – | 2 | $2K | May 29, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Commodore Capital LP | 9.9% | 13G | Mar 16, 2026 | filing ↗ | |
| Commodore Capital Master LP | 9.9% | 13G | Mar 16, 2026 | filing ↗ | |
| Robert Egen Atkinson | 9.9% | 13G | Mar 16, 2026 | filing ↗ | |
| Michael Kramarz | 9.9% | 13G | Mar 16, 2026 | filing ↗ | |
| Coastlands Capital LP | 9.3% | 13G | Jun 4, 2025 | filing ↗ | |
| Coastlands Capital Partners LP | 9.3% | 13G | Jun 4, 2025 | filing ↗ | |
| Coastlands Capital GP LLC | 9.3% | 13G | Jun 4, 2025 | filing ↗ | |
| Coastlands Capital LLC | 9.3% | 13G | Jun 4, 2025 | filing ↗ | |
| Matthew D. Perry | 9.3% | 13G | Jun 4, 2025 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 8.0% | 13G | Mar 13, 2026 | filing ↗ | |
| VIVO Opportunity, LLC | 8.0% | 13G | Mar 13, 2026 | filing ↗ | |
| Eric Easom | 7.9% | 13G | Feb 13, 2026 | filing ↗ | |
| Adjuvant Capital GP, L.P. | 7.9% | 13G | Feb 28, 2025 | filing ↗ | |
| Adjuvant Capital Management, L.L.C. | 7.9% | 13G | Feb 28, 2025 | filing ↗ | |
| Adjuvant Global Health Technology Fund, L.P. | 6.7% | 13G | Feb 28, 2025 | filing ↗ | |
| Millennium Management LLC | 6.3% | 13G | Mar 13, 2026 | filing ↗ | |
| Millennium Group Management LLC | 6.3% | 13G | Mar 13, 2026 | filing ↗ | |
| Israel A. Englander | 6.3% | 13G | Mar 13, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 6.0% | 13G | Mar 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Other events (8.01) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Other events (8.01) | Apr 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 19, 2026 | filing ↗ |
| Earnings (2.02) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 8, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 26, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |